Pharma news
Pharma
Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand. 24 March 2020
Americas
The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court. 19 March 2020
Americas
German authorities have reacted angrily to media reports that US President Donald Trump offered $1 billion to CureVac, a Germany-based company seeking a COVID-19 vaccine, to move its operations to the US. 17 March 2020
Pharma
The US Court of Appeals for the Federal Circuit has rescued one Boehringer Ingelheim patent, covering a type 2 diabetes treatment, from invalidation but affirmed a New Jersey district court’s cancellation of two others. 17 March 2020
Pharma
The World Health Organization has launched a Solidarity Response Fund, offering companies, foundations and individuals the chance to donate to the WHO’s global response to the ongoing COVID-19 pandemic. 16 March 2020
Americas
The University of South Florida Research Foundation has accused medical technology company Hologic of patent infringement, related to diagnosis methods for digital mammography. 12 March 2020
Pharma
The UK Competition and Markets Authority has welcomed a Court of Appeal ruling allowing it to press ahead with cases against Pfizer and Flynn Pharma over the unfair pricing of an epilepsy treatment. 12 March 2020
Pharma
The European Medicines Agency has said that no drug shortages or supply disruptions due to the coronavirus outbreak have been reported, but that a steering group has convened to address the epidemic’s impact on the supply of medicines in the EU. 11 March 2020
Pharma
The AARP has urged the US Court of Appeals for the Ninth Circuit to uphold a newly-formed California law prohibiting the majority of pay-for-delay pharmaceutical settlements. 10 March 2020
Americas
A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit. 10 March 2020